Our previous studies reported that LEF1 is predominantly expressed in ESCC cell lines and tumor tissues and that the positive expression of LEF1 is correlated with aberrant clinicopathological characteristics of ESCC patients [18]. The gene discussed is LEF1; the disease is neoplasm.